apollo
0

Welcome User

Login/Sign Up

Home
Buy Medicines
Lab Tests
Doctor Consult
Circle Membership
insurance
Blogs
Contact Us
Privacy Policy
Return & Refunds
Need Help
Terms and Conditions
  1. Home
  2. Medicine

  3. Baraclude 0.5 mg Oral Solution 210 ML

Baraclude 0.5 mg Oral Solution 210 ML, Pack of 1 Oral Solution
Offers on medicine orders
All offers
axis icici
rxMedicinePrescription drug

Whats That

tooltip

Also Explore

Momverse
Ask Apollo
insurance

Composition :

ENTECAVIR-0.05MG

Manufacturer/Marketer :

Bristol-Myers Squibb India Pvt Ltd

Consume Type :

ORAL

Return Policy :

Not Returnable

Expires on or after :

About Baraclude 0.5 mg Oral Solution

Baraclude 0.5 mg Oral Solution is used to treat chronic hepatitis B virus (HBV) infection. Hepatitis B is a severe liver infection caused by the hepatitis B virus (HBV). It is highly contagious (spreads from one person to another) and spreads through intimate contact with the infected person, direct contact with infected blood, being pricked with a contaminated needle, using a razor or any other personal items with leftovers of infected fluid, or even transfer from mother to baby during birth.

Baraclude 0.5 mg Oral Solution contains Entecavir, an antiviral drug that works by inhibiting viral DNA polymerase enzyme action in the liver cells, which is essential for the virus to multiply. Therefore, it prevents the virus from replicating and reduces the amount of hepatitis B virus in the body.

Take Baraclude 0.5 mg Oral Solution as prescribed by your doctor. You are advised to take Baraclude 0.5 mg Oral Solution for as long as your doctor has prescribed it for you based on your medical condition. Sometimes, you may experience dizziness, headache, nausea, vomiting, drowsiness, extreme tiredness, insomnia (inability to sleep), diarrhoea, or indigestion. Most of these side effects of Baraclude 0.5 mg Oral Solution do not require medical attention and typically resolve on their own over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to Entecavir or any of the ingredients in Baraclude 0.5 mg Oral Solution , inform your doctor before starting treatment. Consult your doctor if you are pregnant, planning to become pregnant, or breastfeeding, as the safety of Entecavir during pregnancy and lactation is not fully established. Effective contraception is recommended during treatment to avoid pregnancy. Baraclude 0.5 mg Oral Solution is not recommended for use in children under 2 years of age. Contact your doctor immediately if you experience symptoms such as persistent nausea, vomiting, or abdominal pain, as these may be signs of lactic acidosis, a rare but serious condition that has occurred with nucleoside analogues like Entecavir, more often in women, especially those who are overweight. Your doctor will regularly monitor your liver and kidney function during treatment. Inform your doctor if you have an HIV infection, kidney disease, or liver problems before starting Baraclude 0.5 mg Oral Solution .

Uses of Baraclude 0.5 mg Oral Solution

Baraclude 0.5 mg Oral Solution is used for the treatment of chronic (long-term) hepatitis B virus (HBV) infection. While it does not cure the infection, it helps lower the amount of HBV in the body, supports liver health, and reduces the risk of complications such as liver damage, cirrhosis, or liver cancer. The specific approved uses of Baraclude 0.5 mg Oral Solution include: <br/>•Treatment of Chronic HBV Infection in Adults: Baraclude 0.5 mg Oral Solution is indicated for adults with chronic HBV infection, including those with compensated liver disease (where the liver is damaged but still functions) and decompensated liver disease (where the liver is severely damaged and no longer functions properly). <br/>•Treatment of Chronic HBV Infection in Pediatric Patients: Baraclude 0.5 mg Oral Solution is also approved for use in children and adolescents aged 2 to under 18 years with chronic HBV infection who have compensated liver disease.<br/>

Directions for Use

  • Baraclude 0.5 mg Oral Solution can be taken on an empty stomach, preferably 2 hours before or after a meal.
  • It is usually taken once daily at the same time each day or as prescribed by your doctor.
  • Shake the bottle well before each use.
  • Use the measuring spoon provided with the pack to measure the dose accurately.
  • To use the spoon, hold it upright (vertically) and slowly fill it to the marking that matches your prescribed dose. With the volume markings facing you, verify that the spoon is filled to the correct mark. Take the medicine by mouth directly from the measuring spoon.
  • Rinse the spoon thoroughly with water and let it air dry after each use.
  • Avoid using regular household spoons, as they may not measure the dose correctly.

Medicinal Benefits

Baraclude 0.5 mg Oral Solution contains Entecavir, an antiviral medication used to treat chronic hepatitis B virus (HBV) infection. It works by inhibiting the HBV DNA polymerase enzyme, which is essential for the virus to replicate inside liver cells. By blocking this enzyme, Baraclude 0.5 mg Oral Solution reduces the production of new viruses in the body, leading to a decrease in viral load. This helps slow the progression of liver damage, lowers the risk of complications such as cirrhosis or liver cancer, and improves overall liver function.

How Baraclude 0.5 mg Oral Solution Works

Baraclude 0.5 mg Oral Solution contains Entecavir, an antiviral drug that works by inhibiting viral DNA polymerase enzyme action in the liver cells, which is essential for the virus to multiply. Therefore, it prevents the virus from replicating and reduces the amount of hepatitis B virus in the body.

Storage

Store in a cool and dry place away from sunlight

What if I have taken an overdose of Baraclude 0.5 mg Oral Solution

Do not take more than the prescribed dose of Baraclude 0.5 mg Oral Solution , as this may lead to an overdose. If you think you have taken too much, contact your doctor or seek medical help right away.

Drug Warnings

Baraclude 0.5 mg Oral Solution should not be used if you are allergic to Entecavir or any of its ingredients. It may cause a rare but serious condition called lactic acidosis, which involves a dangerous buildup of acid in the blood, as well as severe liver problems, so it’s important to report symptoms like nausea, vomiting, or stomach pain right away. Stopping Baraclude 0.5 mg Oral Solution suddenly can lead to a severe flare-up of hepatitis B, so always follow your doctor’s instructions carefully. Individuals with kidney issues may require a lower dose, and their kidney function should be closely monitored during treatment. Baraclude 0.5 mg Oral Solution is not recommended for children under 2 years of age or weighing less than 10 kg because safety and effectiveness have not been established in this group. If you are pregnant or breastfeeding, consult your doctor before using Baraclude 0.5 mg Oral Solution , as its safety during pregnancy and breastfeeding is not fully known. Additionally, if you have both HIV and hepatitis B infections, tell your doctor, since Baraclude 0.5 mg Oral Solution is not effective against HIV and may interfere with HIV treatments. Throughout treatment, your doctor will monitor your condition closely to ensure the medicine is working and to check for any possible resistance to the drug.

Diet & Lifestyle Advise

  • Include a variety of vegetables, fruits, and whole grains, such as brown rice, oats, quinoa, and barley.
  • Eat lean protein such as skinless chicken, fish, beans, and egg whites.
  • Include healthy fats like avocados, olive oil, and nuts.
  • Eat low-fat or non-fat dairy products to minimise damage to the liver.
  • Drink plenty of water to help the body process food more efficiently.
  • Avoid sugary foods, such as cake, cookies, packaged or baked goods, and soda. Also, avoid heavy-salt foods.
  • Avoid foods containing saturated fats, such as fried foods, fatty cuts of meat, sour cream, butter, and other high-fat dairy products, as they may lead to weight gain and result in fatty liver.
  • Avoid smoking and alcohol consumption as they may increase the risk of liver damage.

Habit Forming

No

Therapeutic Class

ANTIVIRALS
bannner image

Alcohol

Caution

The interaction of alcohol with Baraclude 0.5 mg Oral Solution is unknown. Please consult a doctor before consuming alcohol while using Baraclude 0.5 mg Oral Solution .

bannner image

Pregnancy

Caution

Baraclude 0.5 mg Oral Solution is a category C pregnancy drug and is given to pregnant women only if the doctor thinks the benefits outweigh the risks.

bannner image

Breast Feeding

Caution

It is not known whether Baraclude 0.5 mg Oral Solution is excreted in human breast milk. Therefore, consult your doctor before using Baraclude 0.5 mg Oral Solution while breastfeeding. Your doctor will weigh the potential benefits against the possible risks before recommending its use during this time.

bannner image

Driving

Caution

Baraclude 0.5 mg Oral Solution may cause dizziness, drowsiness or tiredness in some people. Therefore, avoid driving or operating heavy machinery if you feel dizzy, drowsy or tired after taking Baraclude 0.5 mg Oral Solution .

bannner image

Liver

Caution

Take Baraclude 0.5 mg Oral Solution with caution, especially if you have liver problems. Your doctor may adjust the dose as required. Please consult a doctor.

bannner image

Kidney

Caution

Take Baraclude 0.5 mg Oral Solution with caution, especially if you have kidney problems. Your doctor may adjust the dose as required. Please consult a doctor.

bannner image

Children

Caution

Baraclude 0.5 mg Oral Solution is not recommended for children under 2 years of age or weighing less than 10 kg due to insufficient safety and effectiveness data. In children aged 2 years and above, Baraclude 0.5 mg Oral Solution should be used only under medical supervision, with doses strictly adjusted based on the child’s weight and clinical condition. Close monitoring of treatment response and potential side effects is essential.

Have a query?

FAQs

Baraclude 0.5 mg Oral Solution is an antiviral medication used to treat chronic hepatitis B virus (HBV) infection in adults and children aged 2 to 18 years.

Baraclude 0.5 mg Oral Solution contains Entecavir, an antiviral drug that works by preventing the viral DNA polymerase enzyme action in the liver cells, which is essential for the virus to multiply. Therefore, it prevents the virus from replicating and reduces the amount of hepatitis B virus in the body.

Yes, hepatitis B virus infection is highly contagious and spreads from one person to another. Therefore, it is recommended to avoid sharing personal items or needles containing an infected person's blood or body fluids.

Baraclude 0.5 mg Oral Solution may cause lactic acidosis (excess of lactic acid in the blood), a rare but severe side effect, especially in women who are very obese. However, if you experience stomach pain, vomiting or nausea while taking Baraclude 0.5 mg Oral Solution , please consult a doctor immediately.

You are not recommended to take Baraclude 0.5 mg Oral Solution with celecoxib (painkiller), as it may increase the blood levels of Baraclude 0.5 mg Oral Solution , leading to more adverse effects and may also affect kidney function. However, please consult your doctor before taking Baraclude 0.5 mg Oral Solution with other medicines.

Baraclude 0.5 mg Oral Solution does not cure hepatitis B virus infection. However, it reduces the amount of hepatitis B virus in the body and improves liver functioning by decreasing liver damage.

Baraclude 0.5 mg Oral Solution is not recommended for hepatitis B patients with HIV infection unless they are taking medicines to treat HIV infection at the same time as Baraclude 0.5 mg Oral Solution may cause HIV infection to become resistant to certain HIV drugs and reduce their effectiveness. Therefore, it is advised to get tested for HIV infection before taking Baraclude 0.5 mg Oral Solution .

You are not recommended to stop taking Baraclude 0.5 mg Oral Solution without consulting your doctor, as it may worsen the infection or cause recurring symptoms. Therefore, take Baraclude 0.5 mg Oral Solution for as long as your doctor has prescribed it. If you experience any difficulty while taking Baraclude 0.5 mg Oral Solution , please consult your doctor.

Country of origin

India

Manufacturer/Marketer address

Bristol-Myers Squibb India Pvt. Ltd., The India Bulls Finance Centre, 6th Floor, Tower 1, Senapati Bapat Marg, Elphinstone (W), Mumbai - 400013
Other Info - BAR0096

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.

Reference

  1. https://www.medicines.org.uk/emc/files/pil.2089.pdf
  2. https://medlineplus.gov/druginfo/meds/a605028.html
  3. https://www.drugs.com/mtm/entecavir.html

Buy best Infections & Infestation products by

whatsapp Floating Button